Effect of urolithins A and B on ectopic endometrial growth in a murine model of endometriosis
Urolithins A and B independently reduced ectopic endometrial growth in a murine endometriosis model without altering body weight or the estrous cycle.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study evaluated whether urolithins A and B alter the growth and survival of endometriotic-like lesions in a surgically induced endometriosis model using female BALB/C mice treated intraperitoneally with 2.5 mg kg−1 day−1 of either urolithin A or urolithin B for 28 days. The authors monitored estrous stage and body weight and then quantified lesions by counting and measuring after excision, alongside assessing epithelial and stromal proliferation and apoptosis in the implants. Urolithin A completely prevented endometriotic-like lesions, whereas urolithin B reduced implant volume, with both treatments lowering cellular proliferation and enhancing apoptosis. The paper’s main limitation is that the work is confined to a mouse model and does not establish clinical relevance for humans, though it is centrally about endometriosis—testing urolithins A and B as modulators of ectopic endometrial lesion growth and survival in endometriosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,447 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (76)
- Active compounds present inRosmarinus officinalis leaves andScutellaria baicalensis root evaluated as new therapeutic agents for endometriosis via openalex
- Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex
- Current and Emerging Therapeutics for the Management of Endometriosis via openalex
- Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. via openalex
- Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis via openalex
- Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice via openalex
- Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis via openalex
- Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis via openalex
- Endometrial Anomalies in Women with Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and infertility: pathophysiology and management via openalex
- Endometriosis and the neoplastic process via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
- Evaluation of the macroscopic growth degree of experimental endometriosis in rats via openalex
- Health-related quality of life in women with endometriosis: a systematic review via openalex
- Immune-inflammation gene signatures in endometriosis patients via openalex
- Individual and combined effects of triptoreline and gestrinone on experimental endometriosis in rats via openalex
- Investigational drugs for the treatment of endometriosis, an update on recent developments via openalex
- In vivo effects of curcumin and deferoxamine in experimental endometriosis via openalex
- Medical Therapies for Endometriosis Differentially Inhibit Stem Cell Recruitment via openalex
- Medical treatment of endometriosis-related pain via openalex
- Natural therapies assessment for the treatment of endometriosis via openalex
- New trends for the medical treatment of endometriosis via openalex
- On-label and off-label drug use in the treatment of endometriosis via openalex
- ORIGINAL ARTICLE: Immune Status, Psychosocial Distress and Reduced Quality of Life in Infertile Patients with Endometriosis via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Peritoneal endometriosis induces time-related depressive- and anxiety-like alterations in female rats: involvement of hippocampal pro-oxidative and BDNF alterations via openalex
- Phytotherapy in endometriosis: an up-to-date review via openalex
- PI3K/AKT pathway is altered in the endometriosis patient’s endometrium and presents differences according to severity stage via openalex
- Plant-derived medicines for treatment of endometriosis: A comprehensive review of molecular mechanisms via openalex
- Potential use of ellagic acid for endometriosis treatment: its effect on a human endometrial cell cycle, adhesion and migration via openalex
- The ellagic acid metabolites urolithin A and B differentially affect growth, adhesion, motility, and invasion of endometriotic cells <i>in vitro</i> via openalex
- The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis via openalex
- The social and psychological impact of endometriosis on women's lives: a critical narrative review via openalex
- W2905704144 via openalex
- W2967214349 via openalex
- W3010924948 via openalex
- W3012573213 via openalex
- W4211081176 via openalex
- W2008988346 via openalex
- W2016150270 via openalex
- W2024421129 via openalex
- W2025055344 via openalex
- W2028650129 via openalex
- W2042592266 via openalex
- W2044623277 via openalex
- W2047475718 via openalex
- W2061310823 via openalex
- W2063880990 via openalex
- W2075153820 via openalex
- W2079426150 via openalex
- W2080304600 via openalex
- W2081012360 via openalex
- W2089453670 via openalex
- W2096022216 via openalex
- W2096790979 via openalex
- W2103023937 via openalex
- W2109698180 via openalex
- W2121370472 via openalex
- W2146166890 via openalex
- W2163388941 via openalex
- W2195412558 via openalex
- W2285812509 via openalex
- W2317475688 via openalex
- W2346306153 via openalex
- W2470574011 via openalex
- W2515016244 via openalex
- W2520524719 via openalex
- W2586669240 via openalex
- W2729098679 via openalex
- W2765399611 via openalex
- W2796123904 via openalex
- W2806655963 via openalex
- W2809356528 via openalex
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-06-14T06:08:20.186862+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:14.728497+00:00